© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
Dermatology
Review examines different ways to reduce costs for atopic dermatitis treatment
September 30, 2022
A review examined the ways in which costs can be reduced for patients with varying types of atopic dermatitis.
Purpuric papules in a child with acute pancreatitis
September 26, 2022
A previously healthy 11-year-old boy presents with purpuric macules and papules symmetrically distributed on his buttocks and upper and lower extremities. What’s the diagnosis?
White oral lesions in neonate with COVID-19
August 17, 2022
A 4-week-old boy presents with creamy white patches on his lips, right and left buccal mucosa, palate, and tongue.
Pediatric psoriasis treatment challenges
August 15, 2022
Investigators have found that there are limited options for treating pediatric psoriasis.
FDA approves ustekinumab to treat pediatric psoriatic arthritis
August 01, 2022
Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ustekinumab as a new treatment option for patients aged 6 years or older with active psoriatic arthritis.
Roflumilast cream 0.3% for plaque psoriasis approved by FDA
July 29, 2022
Arcutis Biotherapeutics’ roflumilast cream will provide relief to patients aged 12 years or older diagnosed with plaque psoriasis.
A case of shin guard dermatitis?
July 27, 2022
A healthy 14-year old boy was evaluated for an intensely pruritic shin rash that developed 2 weeks prior and had been treated with oral antibiotics for 10 days.
Safety, efficacy of berdazimer gel for molluscum contagiosum
July 22, 2022
Stephen Stripling, MD, FAAP, discusses results published in JAMA Dermatology about the efficacy and safety of berdazimer gel 10.3% for the treatment of molluscum contagiosum.
FDA approves ruxolitinib cream 1.5% to treat nonsegmental vitiligo
July 19, 2022
Opzelura (ruxolitinib) cream is the first and only FDA-approved treatment for adult and pediatric patients 12 years of age or older with vitiligo.
Pediatric patients with AD have an increased risk of type 2 inflammatory diseases
July 13, 2022
A better understanding of this atopic diathesis and the atopic march often seen in pediatric patients is necessary to optimally treat and manage the patient population, ideally in a multidisciplinary setting.